PREVALENCE AND CAUSES OF LIVER CIRRHOSIS IN DIFFERENT REGIONS LITERATURE REVIEW

Authors

  • Ravzatov Jasurbek PhD, Associate Professor, Department of Family Physician Training, Andijan State Medical Institute.
  • Nabieva Dildora Head of the Department of Occupational Pathology, Faculty No. 1 and Hospital Therapy, Tashkent Medical Academy, Doctor of Medical Sciences, Professor.

Keywords:

Liver cirrhosis, decompensated cirrhosis, steatohepatitis, hepatitis B, hepatitis C

Abstract

Chronic liver diseases, including fibrosis and cirrhosis, can be associated with chronic malnutrition. Malnutrition, i.e. less than the required amount of food intake (hypoalimentation), is often caused by a misunderstanding of the meaning of the term "liver diet", slowing down of food digestion processes (including secretion of bile acids), metabolic disorders consisting of limitation of protein synthesis and increased catabolism and acceleration of processes.

Downloads

Download data is not yet available.

References

1. Aghdassi AA, Schneider A, Kahl M, et al. Analysis of lifestyle factors in patients with concomitant chronic pancreatitis and liver cirrhosis. Pancreatology. 2017;17(5):698-705

2. Aldana Ledesma JM, Vбzquez Rodrнguez D, Lazcano Becerra M, Garcнa Jimйnez ES, Tapia Calderуn DK, Ibarra Estrada MБ, Fйlix Tйllez FA, Velarde Ruiz Velasco JA. [Comparison of different tools for the evaluation of malnutrition and sarcopenia in patients with liver cirrhosis] Nutr Hosp 2023; 40: 340-346

3. Grungreiff K, Gottstein T, Reinhold D, Blindauer CA. Albumin Substitution in Decompensated Liver Cirrhosis: Don't Forget Zinc. Nutrients 2021; 13; Fernandez J, Angeli P. et al, Efficacy of Albumin Treatment for Patients with Cirrhosis and Infections Unrelated to Spontaneous Bacterial Peritonitis. Clin Gastroenterol Hepatol 2020; 18: 963-973.e14

4. Fagerstrцm C, Frisman GH. Living with liver cirrhosis: a vulnerable life. Gastroenterol Nurs. 2017;40(1):38-46

5. Hansen L, Leo MC, Chang MF, Zaman A, Naugler W, Schwartz J. Symptom distress in patients with end-stage liver disease toward the end of life. Gastroenterol Nurs. 2015;38(3):201-210.

6. Janota B, Krupowicz A, Noras K, Janczewska E. Evaluation of the nutritional status of patients with liver cirrhosis. World J Hepatol 2023; 15(7): 914-924

7. Janota B, Krupowicz A, Noras K, Janczewska E. Evaluation of the nutritional status of patients with liver cirrhosis. World J Hepatol 2023; 15(7): 914-924

8. Kalal C, Benjamin J, Shasthry V, Kumar G, Sharma MK, Joshi YK, Sarin SK. Effect of long-term aggressive nutrition therapy on survival in patients with alcohol-related cirrhosis: A randomized controlled trial. Indian J Gastroenterol 2022; 41: 52-62; Aldana Ledesma JM, Vбzquez Rodrнguez D, Lazcano Becerra M, Garcнa Jimйnez ES, Tapia Calderуn DK, Ibarra Estrada MБ, Fйlix Tйllez FA, Velarde Ruiz Velasco JA. [Comparison of different tools for the evaluation of malnutrition and sarcopenia in patients with liver cirrhosis] Nutr Hosp 2023; 40: 340-346

9. Kim HJ, Chu H, Lee S. Factors inǚuencing on health-related quality of life in South Korean with chronic liver disease. Health Qual Life Outcomes. 2018;16(1):142. doi:10.1186/s12955-018-0964-1.; Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep. 2013;15(1):301.

10. Marra M, Sammarco R, De Lorenzo A, Iellamo F, Siervo M, Pietrobelli A, Donini LM, Santarpia L, Cataldi M, Pasanisi F, Contaldo F. Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview. Contrast Media Mol Imaging 2019; 2019: 3548284

11. Łapiński TW, Łapińska M. Nutritional status in patients with liver cirrhosis. Clinical and Experimental Hepatology. 2019;5(1):30-34. doi:10.5114/ceh.2019.83154

12. Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med 2016; 9: 229-255

13. Loria A, Escheik C, Gerber NL, Younossi ZM. Quality of life in cirrhosis. Curr Gastroenterol Rep. 2013;15(1):301.

14. Luengpradidgun L, Chamroonkul N, Sripongpun P, Kaewdech A, Tanutit P, Ina N, Piratvisuth T. Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients. BMC Gastroenterol 2022; 22: 159

15. Marra M, Sammarco R, De Lorenzo A, Iellamo F, Siervo M, Pietrobelli A, Donini LM, Santarpia L, Cataldi M, Pasanisi F, Contaldo F. Assessment of Body Composition in Health and Disease Using Bioelectrical Impedance Analysis (BIA) and Dual Energy X-Ray Absorptiometry (DXA): A Critical Overview. Contrast Media Mol Imaging 2019; 2019: 3548284

16. Nishikawa H, Yoh K, Enomoto H, Ikeda N, Takashima T, Aizawa N, Nishimura T, Nishiguchi S, Iijima H. Predictors for Grip Strength Loss in Patients With Chronic Liver Diseases. In Vivo 2021; 35: 363-371

17. Pazokian, Marzieh & Esmaeili, Maryam. (2019). Quality of Life in Patients With Liver Cirrhosis: A Systematic Review. Hospital Practices and Research. 4. 111-116. 10.15171/hpr.2019.23

18. Tsien C, Davuluri G, Singh D, et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis. Hepatology 2015; 61: 2018-2029

19. Volk ML, Kanwal F. Quality of Care in the Cirrhotic Patient. Clin Transl Gastroenterol. 2016;7:e166

20. Wang Q, Liu M, Xu L, et al. Transcriptome analysis reveals the molecular mechanism of hepatic fat metabolism disorder caused by Muscovy duck reovirus infection. Avian Pathol 2018; 47: 127-139

21. Wang ZG, Dou XB, Zhou ZX, et al. Adipose tissue-liver axis in alcoholic liver disease. World J Gastrointest Pathophysiol 2016; 7: 17-26.

Downloads

Published

2026-01-05

How to Cite

PREVALENCE AND CAUSES OF LIVER CIRRHOSIS IN DIFFERENT REGIONS LITERATURE REVIEW. (2026). Multidisciplinary Journal of Science and Technology, 6(1), 51-54. https://mjstjournal.com/index.php/mjst/article/view/6463